Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000721748-13-000563
Filing Date
2013-08-27
Accepted
2013-08-27 14:16:42
Documents
10
Period of Report
2012-11-30

Document Format Files

Seq Description Document Type Size
1 gbiq10k113012.htm 10-K 393022
2 CERTIFICATIONS gbiq311.htm EX-31.1 9714
3 CERTIFICATIONS gbiq312.htm EX-31.2 9503
4 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL OFFICER gbiq321.htm EX-32 3892
  Complete submission text file 0000721748-13-000563.txt   3391889

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE gbiq-20121130.xml EX-101.INS 221117
6 XBRL SCHEMA FILE gbiq-20121130.xsd EX-101.SCH 21586
7 XBRL CALCULATION FILE gbiq-20121130_cal.xml EX-101.CAL 19268
8 XBRL DEFINITION FILE gbiq-20121130_def.xml EX-101.DEF 32034
9 XBRL LABEL FILE gbiq-20121130_lab.xml EX-101.LAB 131119
10 XBRL PRESENTATION FILE gbiq-20121130_pre.xml EX-101.PRE 114718
Mailing Address 2711 CENTERVILLE SUITE 400 WILMINGTON DE 19808
Business Address 2550 BATES RD. SUITE 212 MONTREAL A8 H3S 1A7 302 288 0658
Global Biotech Corp. (Filer) CIK: 0001126162 (see all company filings)

EIN.: 980229951 | Fiscal Year End: 0228
Type: 10-K | Act: 34 | File No.: 000-33271 | Film No.: 131062451
SIC: 7389 Services-Business Services, NEC